Εμφανίζονται 1 - 8 Αποτελέσματα από 8 για την αναζήτηση '"суточное мониторирование электрокардиограммы"', χρόνος αναζήτησης: 0,48δλ Περιορισμός αποτελεσμάτων
  1. 1
  2. 2
    Academic Journal

    Πηγή: Medicine of Ukraine; № 8(234) (2019); 16-23
    Лекарства Украины; № 8(234) (2019); 16-23
    Ліки України; № 8(234) (2019); 16-23

    Περιγραφή αρχείου: application/pdf

  3. 3
    Academic Journal

    Πηγή: The Russian Archives of Internal Medicine; Том 9, № 1 (2019); 44-51 ; Архивъ внутренней медицины; Том 9, № 1 (2019); 44-51 ; 2411-6564 ; 2226-6704 ; 10.20514/2226-6704-2019-9-1

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.medarhive.ru/jour/article/view/882/759; https://www.medarhive.ru/jour/article/view/882/767; Мухин Н.А. Нефрология. Национальное руководство. Краткое издание. Москва. 2016; 608 с.; Turakhia M.P., Blankestijn P.J., Carrero J.J. et al. Chronic kidney disease and arrhythmias: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. European heart journal. 2018;39:24:2314-2325. https://doi.org/10.1093/eurheartj/ehy060.; Masho Y., Shigematsu T. Arteriosclerosis and vascular calcification in chronic kidney disease (CKD) patients. Clinical calcium. 2007; 17(3): 354-359. DOI: CliCa0703354359.; Муркамилов И.Т., Айтбаев К.А., Сарыбаев А.Ш. и др. Взаимосвязь ремоделирования сонных артерий и геометрии левого желудочка у больных с хроническим гломерулонефритом. Кардиология. 2018; 58(4): 45–52. DOI:10.18087/cardio.2018.4.10108.; Волгина Г.В. Гипертрофия левого желудочка сердца у больных с додиализной хронической почечной недостаточностью. Кардиоваскулярная терапия и профилактика. 2002; 1(4): 68-75.; Ali T., Idrees M.K., Shoukat., Akhtar S.F. Left ventricular hypertrophy among predialysis chronic kidney disease patients: Sindh institute of urology and transplantation experience. Saudi J Kidney Dis Transpl. 2017; 28: 1375-1380. DOI:http://www.sjkdt.org/text.asp?2017/28/6/1375/220856.; Каретникова В.Н., Калаева В.В., Евсеева М.В. и др. Роль хронической болезни почек в оценке риска неблагоприятного течения госпитального периода инфаркта миокарда с подъемом сегмента ST. Тер. архив. 2016; 88(6): 26-32. DOI:10.17116/terarkh201688626-32.; Chan M.Y., Becker R.C., Sim L.L. et al. Reperfusion strategy and mortality in ST-elevation myocardial infarction among patients with and without impaired renal function. Ann Acad Med Singapore. 2010; 39(3): 179-184.; Ahmed A., Campbell R.C. Epidemiology of chronic kidney disease in heart failure. Heart failure clinics. 2008; 4(4): 387-399. https://doi.org/10.1016/j.hfc.2008.03.008.; House A.A. Management of Heart Failure in Advancing CKD: Core Curriculum 2018. Am J Kidney Dis. 2018: 72(2): 284-295. DOI:10.1053/j.ajkd.2017.12.006.; Feldberg J., Patel P., Farrell A. et al. A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation. Nephrology Dialysis Transplantation. 2018. https://doi.org/10.1093/ndt/gfy031.; Arnold J., Sims D., Ferro C.J. Modulation of stroke risk in chronic kidney disease. Clinical kidney journal. 2015; 9(1): 29-38. https://doi.org/10.1093/ckj/sfv136.; KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements. 2013; 3: 1-150.; Mancia G., Fagard R., Narkiewicz K. et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Hypertension. 2013; 31: 1281-1357. https://doi.org/10.3109/08037051.2013.812549.; Devereux R.B., Alonso D.R., Lutas E.M. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. The American journal of cardiology. 1986; 57(6): 450-458. https://doi.org/10.1016/0002-9149(86)90771-X.; Williams B., Mancia G., Spiering W. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European heart journal. 2018; 39(33): 3021-3104. https://doi.org/10.1093/eurheartj/ehy339.; Методы статистической обработки медицинских данных: Методические рекомендации для ординаторов и аспирантов медицинских учебных заведений, научных работников / сост.: Кочетов А.Г., Лянг О.В., Масенко В.П., Жиров И.В., Наконечников С.Н., С.Н. Терещенко — М.: РКНПК. 2012; 42 с.; Major R.W., Cheng M.R., Grant R.A. et al. Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis. PloS one. 2018; 13: 3. С. e0192895. https://doi.org/10.1371/journal.pone.0192895.; Mancia G., Fagard R., Narkiewicz K. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood pressure. 2013; 22(4): 193-278. https://doi.org/10.3109/08037051.2013.812549.; Моисеев В.С., Мухин Н.А., Смирнов А.В. и др. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардио-нефропротекции. Российский кардиологический журнал. 2014; 8: 7-37. DOI:10.15829/1560-4071-2014-8-7-37.; Go A.S., Chertow G.M., Fan D. et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine. 2004; 351(13): 1296-1305. DOI:10.1056/NEJMoa041031.; Subbiah A.K., Chhabra Y.K., Mahajan S. Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup. Heart Asia. 2016; 8(2): 56-61. http://dx.doi.org/10.1136/heartasia-2016-010809.; Neter J.E., Stam B.E., Kok F.J. et al. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003; 42: 878–884. http://dx.doi.org/10.1161/01.HYP.0000094221.86888.AE.; Rao M.V., Qiu Y., Wang C., Bakris G. Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004. Am. J. Kidney Dis. 2008; 51:4: S30-S37. https://doi.org/10.1053/j.ajkd.2007.12.012.; Rimoldi S.F., Scherrer U., Messerli F.H. Secondary arterial hypertension: when, who, and how to screen? Eur. Heart J. 2013; 35(19): 1245-1254. https://doi.org/10.1093/eurheartj/eht534.; Morse., Stephen A., Dang An, Thakur Vashu. et al. Hypertension in Chronic Dialysis Patients: Pathophysiology, Monitoring, and Treatment. Am. J. Med. Sciences. 2003; 325(4): 194-201. https://doi.org/10.1097/00000441-200304000-00005.; Naser N., Dilic M., Durak A. et al. The Impact of Risk Factors and Comorbidities on The Incidence of Atrial Fibrillation. Materia socio-medica. 2017; 29(4): 231-236. DOI:10.5455/msm.2017.29.231-236.; Kirchhof P., Benussi S., Kotecha D. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. European Heart Journal. 2016; 37: 2893-2962. https://doi.org/10.1093/eurheartj/ehw210.; Alonso A., Lopez F.L., Matsushita K. et al. Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011; 123(25): 2946-2953. DOI:10.1161/CIRCULATIONAHA.111.020982.; Bagshaw S.M., Cruz D.N., Aspromonte N. et al. Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant. 2010; 25: 1406-1416. https://doi.org/10.1093/ndt/gfq066.; Муркамилов И.Т., Айтбаев К.А., Фомин В.В., Юсупов Ф.А. Субклиническое ремоделирование каротидных артерий при хроническом гломерулонефрите. Архивъ внутренней медицины 2017; 7(4): 300-305. https://doi.org/10.20514/2226-6704-2017-7-4-300-305.; Муркамилов И.Т., Сабиров И.С., Муркамилова Ж.А. и др. Стратификация нефроцеребрального и сердечно-сосудистого риска при хронических гломерулонефритах (обзор литературы). Архивъ внутренней медицины. 2018; 8(6): 418-423. https://doi.org/10.20514/2226-6704-2018-8-6-418-423.; Verdecchia P., Schillaci G., Borgioni C. et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol. 1995; 25(4): 871-878. DOI:10.1016/0735-1097(94)00424-O.; Muiesan M.L., Salvetti M., Monteduro C. et al. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension. 2004; 43:4:731-738. DOI:10.1161/01.HYP.0000121223.44837.de.; Koren M.J., Devereux R.B., Casale P.N. et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991; 114(5): 345-352. DOI:10.7326/0003-4819-114-5-345.; Пьянкина О.В., Татаринцев П.Б., Рагозин О.Н. Влияние уремических факторов на процессы ремоделирования периферических сосудов у больных хронической болезнью почек. Современные проблемы науки и образования. 2013; 1: URL: http://www.science-education.ru/107-8509.; Pelisek J., Hahntow I.N., Eckstein H.H. Impact of chronic kidney disease on carotid plaque vulnerability. J Vasc Surg. 2011; 54(6): 1643-1649. https://doi.org/10.1016/j.jvs.2011.05.049; Levine H.J. Rest heart rate and life expectancy. Journal of the American College of Cardiology. 1997; 30(4): 1104-1106.; Levy R.L., White P.D., Stroud W.D., Hillman C.C. Transient tachycardia: prognostic significance alone and in association with transient hypertension. JAMA. 1945; 129(9): 585-588. DOI:10.1001/jama.1945.02860430001001.; Gillman M., Kannel W., Belanger A., D`Agostino R. Influence of heart rate on mortality among persons with hypertension: The Framingam study Am Heart J. 1993; 125(4): 1148-1154. https://doi.org/10.1016/0002-8703(93)90128-V.; Schwartz R.J. The neural control of heart rate and risk stratification after myocardial infarction. Eur Heart J. 1999; 1 (Suppl H): H33-H43.; Fusrer V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (I). N Engl J Med. 1992; 326(4): 242-250. DOI:10.1056/NEJM199201233260406.; https://www.medarhive.ru/jour/article/view/882

  4. 4
    Academic Journal

    Πηγή: Rational Pharmacotherapy in Cardiology; Vol 13, No 3 (2017); 403-408 ; Рациональная Фармакотерапия в Кардиологии; Vol 13, No 3 (2017); 403-408 ; 2225-3653 ; 1819-6446 ; 10.20996/1819-6446-2017-13-3

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.rpcardio.com/jour/article/view/1493/1497; Gorenek B., Blomstrom Lundqvist C., Brugada Terradellas J., et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Europace. 2014;16:1655-73.; Rahimi K., Watzlawek S., Thiele H., et al. Incidence, time course, and predictors of early malignant ventricular arrhythmias after non-ST-segment elevation myocardial infarction in patients with early invasive treatment. Eur Heart J. 2006;27:1706-11.; Gogolashvili N.G., Litvinenko M.V., Pochikaeva T.N., et al. Ventricular arrhythmia prevalence and treatment with omega-3 polyunsaturated fatty acids in patients who suffered myocardial infarction within the last year. Kardiovaskulyarnaya Terapiya i Profilaktika. 2011;10(5):57-62. (In Russ.) [Гоголашвили Н.Г., Литвиненко М.В., Почикаева Т.Н. и др. Частота желудочковых аритмий и возможности их лечения препаратом омега-3 полиненасыщенных жирных кислот у больных в течение года после инфаркта миокарда. Кардиоваскулярная Терапия и Профилактика. 2011;10(5):57-62].; Gogolashvili N.G., Litvinenko M.V., Pochikaeva T.N. et al. Possibilities of apreparation omega-3 polyunsaturated fatty acids in the treatment of patients with ventricular arrhythmias and myocardial infarction. Kardiologiia. 2011;51(8):28-31. (In Russ.) [Гоголашвили Н.Г., Литвиненко М.В., Почикаева Т.Н. и др. Возможности препарата омега-3 полиненасыщенных жирных кислот в лечении больных с желудочковыми нарушениями ритма и инфарктом миокарда в анамнезе. Кардиология. 2011;51(8):28-31].; Parmon E.V., Treshkur T.V., Shlyakhto E.V. Idiopathic ventricular arrhythmias (problem analysis). Vestnik Aritmologii. 2003;31:60-71. (In Russ.) [Пармон Е.В., Трешкур Т.В., Шляхто Е.В. Идиопатические желудочковые нарушения ритма (анализ проблемы). Вестник Аритмологии. 2003;31: 60-71].; Hwang J.K., Park S.J., On Y.K., et al. Clinical characteristics and features of frequent idiopathic ventricular premature complexes in the Korean population. Korean Circ J. 2015;45(5):391-7.; Cheriyath P., He F., Peters I., et al. Relation of atrial and/or ventricular premature complexes on a two-minute rhythm strip to the risk of sudden cardiac death (the atherosclerosis risk in communities [ARIC] study). Am J Cardiol. 2011;107(2):151-5.; Ephrem G., Levine M., Friedmann P., Schweitzer P. The prognostic significance of frequency and morphology of premature ventricular complexes during ambulatory holter monitoring. Ann Noninvasive Electrocardiol. 2013;18(2):118-25.; Agarwal S.K., Simpson R.J. Jr., Rautaharju P., et al. Relation of ventricular premature complexes to heart failure (from the Atherosclerosis Risk In Communities [ARIC] Study). Am J Cardiol. 2012;109(1): 105-9.; Piccini J.P., White J.A., Mehta R.H., et al. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes. Circulation. 2012;126(1): 41-9.; Mamchur S.E., Ardashev A.V. Sudden cardiac death and Wolff-Parkinson-White syndrome. Vestnik Aritmologii. 2014;76:30-6. (In Russ.) [Мамчур С.Е., Ардашев А.В. Внезапная сердечная смерть и синдром Вольфа-Паркинсона-Уайта. Вестник Аритмологии. 2014;76:30-6].; Dukes J.W., Dewland T.A., Vittinghoff E., et al. Ventricular ectopy as a predictor of heart failure and death. J Am Coll Cardiol. 2015;66(2):101-9.; Murakoshi N., Aonuma K. Epidemiology of arrhythmias and sudden cardiac death in Asia. Circ J. 2013;77:2419-31.; Hingorani P., Karnad D.R., Natekar M., et al. Baseline and new-onset morphologic ECG abnormalities in healthy volunteers in phase I studies receiving placebo: changes over a 6-week follow-up period. J Clin Pharmacol. 2014;54(7):776-84.; Chiang B.N., Perlman L.V., Fulton М. Predisposing factors in sudden cardiac death in Techumsem (Michigan): A prospective study. Circulation. l970;41(1):31-4.; De Bacquer D., De Backer G., Kornitzer M. Prevalence of ECG findings in large population based samples of men and women. Heart. 2000;84(6):625-33.; Klich A., Kocemba J., Potocka-Plazak К. Rhythm and conduction disorders among the adult population. Epidemiologic data. Przegl Lek. 1994;51(2):104-6.; Gupta R., Sharma S. Prevalence of asymptomatic electrocardiographic abnormalities in a rural population. J Assoc Physicians India. 1996;44(11):775-7.; Hirose H., Ishikawa S., Gotoh T., et al. Cardiac mortality of premature ventricular complexes in healthy people in Japan. J Cardiol. 2010;56(1):23-6.; Lok N.S., Lau C.P. Prevalence of palpitations, cardiac arrhythmias and their associated risk factors in ambulant elderly. Int J Cardiol. 1996;54(3):231-6.; Kiatchoosakun S., Pachirat O., Chirawatkul А., et al. Prevalence of cardiac arrhythmias in Thai community. J Med Assoc Thai. 1999;82(7):727-33.; Klich-Raczka A., Zyczkowska J., Grodzicki T. Electrocardiogram in centenarians. Kardiol Pol. 2003;58(4):275-81.; Molander U., Dey D.K., Sundh V., Steen В. ECG abnormalities in the elderly: prevalence, time and generation trends and association with mortality. Aging Clin Exp Res. 2003;15(6):488-93.; Gogolashvili N.G., Novgorodtseva N.Ia., Polikarpov L.S. The frequency of heart rhythm disturbances in rural native population of Yakutia. Sibirskij Medicinskij Zurnal. 2004;2:79-82. (In Russ.). [Гоголашвили Н.Г., Новгородцева Н.Я., Поликарпов Л.С. Частота аритмий сердца в популяции коренного сельского населения Якутии. Сибирский Медицинский Журнал. 2004; 2: 79-82].; Gogolashvili N.G., Novgorodtseva N.Ia., Polikarpov L.S., Karpov R.S. Incidence of heart rate disorders in rural population of Krasnoiarsk region. Ter Arkhiv. 2004;76(1):41-4. (In Russ.). [Гоголашвили Н.Г., Новгородцева Н.Я., Поликарпов Л.С., Карпов Р.С. Частота аритмий сердца в популяции сельского населения Красноярского края. Терапевтический Архив. 2004; 76(1):41-4].; Simpson R.J. Jr., Cascio W.E., Schreiner P.J., et al. Prevalence of premature ventricular contractions in a population of African American and white men and women: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2002;143(3):535-40.; Kamel H., Elkind M.S., Bhave P.D., et al. Paroxysmal supraventricular tachycardia and the risk of ischemic stroke. Stroke. 2013;44(6):1550-4.; Orejarena L.A., Vidaillet H.Jr., DeStefano F., et al. Paroxysmal supraventricular tachycardia in the general population. J Am Coll Cardiol. 1998;31(1):150-7.; Baratta L., Maffeo N., Tubani L., et al. Arrhythmias in the aged: prevalence and correlation with symptoms. Recenti Prog Med. 1996;87(3):96-101.; Paparella N., Alboni P. Classification and prevalence of supraventricular tachyarrhythmia. Cardiologia 1991;36(8):7-10.; Manolio T.A., Furberg C.D., Rautaharju Р.М., et al. Cardiac arrhythmias on 24-h ambulatory electrocardiography in older women and men: the Cardiovascular Health Study. J Am Coll Cardiol. 1994;23(4):916-25.; Hingorani P., Karnad D.R., Rohekar P., et al. Arrhythmias seen in baseline 2-hour Holter ECG recordings in healthy normal volunteers during phase 1 clinical trials. J Clin Pharmacol. 2016;56(7): 885-93.; Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Fram-ingham Study. Stroke. 1991;22(8):983-8.; Benjamin E.J., Wolf P.A., D’Agostino R.B., et al. Impact of atrial fibrillation on the risk of death: the Fram-ingham Heart Study. Circulation. 1998;98(10):946-52.; Kannel W.B., Abbott R.D., Savage D.D., McNamara P.M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med. 1982;306(17):1018-22.; Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370-5.; Murphy N.F., Simpson C.R., Jhund P.S., et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart. 2007;93(5):606-12.; Wilke T., Groth A., Mueller S., et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace. 2013;15(4):486-93.; Claes N., Van Laethem C., Goethals M., et al. Prevalence of atrial fibrillation in adults participating in a large-scale voluntary screening programme in Belgium. Acta Cardiol. 2012;67(3): 273-8.; Schnabel R.B., Wilde S., Wild P.S., et al. Atrial fibrillation: its prevalence and risk factor profile in the German general population. Dtsch Arztebl Int. 2012;109(16):293-9.; Meschia J.F., Merrill P., Soliman E.Z., et al. Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Stroke. 2010;41(4):581-7.; Mandalenakis Z., Von Koch L., Eriksson H., et al. The risk of atrial fibrillation in the general male population: a lifetime follow-up of 50-year-old men. Europace. 2015;17(7):1018-22.; Schnabel R.B., Johannsen S.S., Wild P.S., Blankenberg S. Prevalence and risk factors of atrial fibrillation in Germany: data from the Gutenberg Health Study. Herz. 2015;40(1):8-15.; Iwahana H., Ishikawa S., Ishikawa J., et al. Atrial fibrillation is a major risk factor for stroke, especially in women: the Jichi Medical School cohort study. J Epidemiol. 2011;21(2):95-101.; Li Y., Wu Y.F., Chen K.P., et al. Prevalence of atrial fibrillation in China and its risk factors. Biomed Environ Sci. 2013;26(9):709-16.; Svennberg E., Engdahl J., Al-Khalili F., et al. Mass screening for untreated atrial fibrillation: The STROKE-STOP Study. Circulation. 2015;131(25):2176-84.; Engdahl J., Andersson L., Mirskaya M., Rosenqvist M. Stepwise screening of atrial fibrillation in a 75-year old population: implications for stroke prevention. Circulation. 2013;127(8):930-7.; Hendrikx T., Hornsten R., Rosenqvist M., Sandstrom H. Screening for atrial fibrillation with baseline and intermittent ECG recording in an out-of-hospital population. BMC Cardiovasc Disord. 2013;13:41.; Inohara T., Kohsaka S., Okamura T., et al. Long-term outcome of healthy participants with atrial premature complex: a 15-year follow-up of the NIPPON DATA 90 cohort. PLoS One. 2013;8(11):e80853.; Murakoshi N., Xu D., Sairenchi T., et al. Prognostic impact of supraventricular premature complexes in community-based health checkups: the Ibaraki Prefectural Health Study. Eur Heart J. 2015;36(3): 170-8.; Qureshi W., Shah A.J., Salahuddin T., Soliman E.Z. Long-term mortality risk in individuals with atrial or ventricular premature complexes (results from the Third National Health and Nutrition Examination Survey). Am J Cardiol. 2014;114(1):59-64.; Larsen B.S., Kumarathurai P., Falkenberg J., et al. Excessive atrial ectopy and short atrial runs increase the risk of stroke beyond incident atrial fibrillation. J Am Coll Cardiol. 2015;66(3):232-41.; Agarwal S.K., Chao J., Peace F., et al. Premature ventricular complexes on screening electrocardiogram and risk of ischemic stroke. Stroke. 2015;46(5):1365-7.; Lee V., Hemingway H., Harb R., et al. The prognostic significance of premature ventricular complexes in adults without clinically apparent heart disease: a meta-analysis and systematic review. Heart. 2012;98(17):1290-8.; Ataklte F., Erqou S., Laukkanen J., Kaptoge S. Meta-analysis of ventricular premature complexes and their relation to cardiac mortality in general populations. Am J Cardiol. 2013;112(8):1263-70.; https://www.rpcardio.com/jour/article/view/1493

  5. 5
  6. 6
  7. 7
  8. 8